CDKN1A and sarcoma: The second most frequently up-regulated gene was cyclin-dependent kinase inhibiton 1A (CDKN1A), a downstream target of p53, has has already been shown to be involved in cell cycle arrest and apoptosis induction by doxorubicin in sarcoma cells.